23.11.2020
Aleksander Aszkiełowicz M.D. from the Department of Anaesthesiology & Intensive Care of the MUG received funding for the two-year project entitled Impact of continuous veno-venous hemodiafiltriation on efficacy of administration of prophylactic doses of enoxaparin and fondaparinux in critically ill patients, from the Baxter company. The value of the recived grant is 37 092 $.
This kind of research is a grant opportunity that allows scientists around the world to submit their research protocol for review by Baxter. The funding criteria assume that the researcher and his institution have full control over the protocol, are the owners of the data, and the company acts as the sponsor of the project by providing financial resources or assistance in the form of products and other specialized services depending on the individual’s needs.